Delivery Order SPE2DB24D2101-SPE2DB25FKMZH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,460.20 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger relationship with DLA. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,821.85 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 unit vials. This firm fixed price contract was competitively awarded without set-aside designation and is scheduled for completion by August 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials, with an ultimate completion date of August 4, 2025. This is a non-set-aside contract awarded competitively to the pharmaceutical distributor's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within AmerisourceBergen's broader federal...
- This is a $11,642.60 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 200 unit vials of BOTOX. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of prescription medications, medical supplies, and equipment to federal agencies, including the military. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,767.00 firm fixed-price contract is for the delivery of 4,568,530,658 units of BOTOX 100 unit vials, with a completion date of July 3, 2025. The contract is not set aside for any specific socioeconomic category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMZHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,613.60 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This competitively awarded, firm fixed-price contract has a completion date of August 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's existing federal contract vehicle with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with DLA and other government healthcare entities, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal procurement requirements through open competition has established it as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/1/25 |